CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zhongyuan Union Cell & Gene Engineering Corp Ltd Company Snapshot
Zhongyuan Union Cell & Gene Engineering Corp Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhongyuan Union Cell & Gene Engineering Corp Ltd with three other companies in this sector in China: Jiangxi Boya Bio-Pharmaceutical Co Ltd (2015 sales of 543.10 million Chinese Renmimbi [US$79.23 million] of which 63% was Blood Plasma), Tianjin Ringpu Bio Technology Co Ltd (792.32 million Chinese Renmimbi [US$115.58 million] of which 60% was Veterinary Biological Products), and Chongqing Zhifei Biological Products Co Ltd (711.35 million Chinese Renmimbi [US$103.77 million] of which 99% was Biological Product).

Sales Analysis. During the year ended December of 2015, sales at Zhongyuan Union Cell & Gene Engineering Corp Ltd were 706.86 million Chinese Renmimbi (US$103.12 million). This is an increase of 50.1% versus 2014, when the company's sales were 470.92 million Chinese Renmimbi. This was the fourth straight year of sales growth at Zhongyuan Union Cell & Gene Engineering Corp Ltd. Sales of Other Operations saw an increase of 23.9% in 2015, from 21.27 million Chinese Renmimbi to 26.34 million Chinese Renmimbi. Not all segments of Zhongyuan Union Cell & Gene Engineering Corp Ltd experienced an increase in sales in 2015: sales of Scientific Research Service fell 5.1% to 425.51 million Chinese Renmimbi. Zhongyuan Union Cell & Gene Engineering Corp Ltd also experienced decreases in sales in Cosmetics Manufacturing (down 1.2% to 7.16 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhongyuan Union Cell & Gene Engineering Corp Ltd
  Stock Performance Chart for Zhongyuan Union Cell & Gene Engineering Corp Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/12/2016): 26.80
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Zhongyuan Union Cell & Gene Engineering Corp Ltd Key Data:
  Ticker: 600645 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 706,860,698
(Year Ending Jan 2016).
Employees: 1,700
  Currency: Chinese Renmimbi Market Cap: 10,342,852,015
  Fiscal Yr Ends: December Shares Outstanding: 385,927,314
  Share Type: A Gu Closely Held Shares: 136,044,588
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.